Medical Editor: John P. Cunha, DO, FACOEP
Aminosyn-PF 7%, Sulfite-Free (amino acid injection, pediatric formula) is a combination of amino acids used for the nutritional support of infants (including those of low birth weight) and young children requiring TPN via either central or peripheral infusion routes. Parenteral nutrition with Aminosyn-PF 7% is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where (1) the alimentary tract by the oral gastrostomy, or jejunostomy route, cannot or should not be used or adequate protein intake is not feasible by these routes, (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. Common side effects of Aminosyn-PF 7%, include:
- injection site reactions) skin redness, inflammation, blood clots, and swelling)
- fever, and
The total daily dose of Aminosyn-PF 7% solution depends on the daily protein requirements and on the patient's metabolic and clinical response. Aminosyn-PF 7% may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Aminosyn-PF 7% should be used only if prescribed. Consult your doctor before breastfeeding.
Our Aminosyn-PF 7%, Sulfite-Free (amino acid injection, pediatric formula) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Local reactions consisting of erythema, phlebitis and thrombosis at the infusion site have occurred with peripheral intravenous infusion of amino acids particularly if other substances, such as antibiotics, are also administered through the same site. In such cases the infusion site should be changed promptly to another vein. Use of large peripheral veins, inline filters, and slowing the rate of infusion may reduce the incidence of local venous irritation. Electrolyte additives should be spread throughout the day. Irritating additive medications may need to be injected at another venous site.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Aminosyn PF 7 (Amino Acid Injection 7% Pediatric Formula)
© Aminosyn PF 7 Patient Information is supplied by Cerner Multum, Inc. and Aminosyn PF 7 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.